Is a 3 mm nodule appearing 1 month after partial nephrectomy for T1a chromophobe (renal cell carcinoma) located in the fat anterior to the psoas muscle below the lower pole of the kidney scar tissue?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

A 3 mm nodule appearing 1 month after partial nephrectomy for T1a chromophobe renal cell carcinoma that is located in the fat anterior to the psoas muscle below the lower pole of the kidney is most likely scar tissue rather than recurrent tumor. The small size (3 mm), short time frame (1 month post-surgery), and location in the surgical field are all consistent with normal healing processes. Chromophobe renal cell carcinomas typically have a favorable prognosis with low recurrence rates, especially for small T1a tumors that have been completely resected, as noted in a study published in the Asian journal of urology 1. However, standard follow-up imaging at 3-6 month intervals is still recommended to monitor for any changes in the nodule's size or characteristics, as suggested by the Journal of endourology 2. If the nodule remains stable or decreases in size on subsequent imaging, this would further support that it represents benign post-surgical changes rather than tumor recurrence. Some studies have reported rare cases of metastasis to unusual locations, such as the psoas muscle, but these are extremely rare and typically occur much later than 1 month post-surgery, as reported in the International journal of urology 3. Given the low risk of recurrence and the likelihood of post-surgical changes, imaging surveillance can be safely deferred until 1 year after surgery, as recommended by the Journal of endourology 2, but close monitoring and clinical judgment should always be exercised. Key factors to consider in the management of this patient include:

  • The natural history of chromophobe renal cell carcinoma, which is generally favorable, as described in Annals of medicine and surgery 4
  • The potential for post-surgical changes to mimic recurrence on imaging, as discussed in the Journal of endourology 2
  • The importance of long-term follow-up to detect any potential recurrence or metastasis, as highlighted in the International journal of surgical pathology 5

Related Questions

Is a 3mm nodule, visible on CT imaging 3 years after partial nephrectomy for stage 1 Chromophobe Renal Cell Carcinoma (RCC), located in the fat anterior to the psoas muscle below the lower pole of the left kidney, likely benign?
What is the significance of a persistent 3 mm nodule anterior to the psoas muscle, adjacent to the left kidney, after partial nephrectomy for Chromophobe renal cell carcinoma (RCC)?
What is the significance of a 3 mm nodule found in the fat anterior to the psoas muscle, below the lower pole of the left kidney, on imaging 3 years after a partial nephrectomy for a 1.3 cm exophytic Chromophobe renal cell carcinoma (RCC)?
What is the significance of a 3 mm nodule near the left kidney in a patient with a history of partial nephrectomy for Chromophobe renal cell carcinoma (RCC)?
What is the clinical significance of a benign soft tissue mass and a stable 3 mm nodule in the fat anterior to the psoas muscle in a patient with a history of partial nephrectomy for chromophobe renal cell carcinoma?
What are the effective communication strategies when educating a pregnant woman about the potential side effects of taking anxiolytic (anxiety) medication, such as benzodiazepines (e.g., alprazolam (Xanax))?
What is the treatment for pneumonia?
Is a 3 mm nodule appearing 1 month in the fat anterior to the psoas muscle (psoas major) below the lower pole of the kidney consistent with scar tissue?
What is the recommended frequency for bilirubin (blood bilirubin level) testing in a neonate undergoing phototherapy for hyperbilirubinemia?
What is the effect of taking Famotidine 20 mg twice a day?
What is the effect of Famotidine (Pepcid) 20 milligrams (mg) twice daily (bid)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.